Columbia Laboratories is a U.S.-based global pharmaceutical company committed to the development and commercialization of products for men’s and women’s healthcare, as well as endocrine-related needs.

Columbia delivers these solutions through its proprietary Bioadhesive Delivery System (BDS), which uses the principle of bioadhesion to administer medication. This technique can deliver hormones and other compounds that are difficult to deliver. Its ability to deliver peptides is under investigation. This technology provides for numerous additional applications in the future.

For more information visit www.columbialabs.com